“As the first biosimilar to Simponi (golimumab) to gain approval in the European market, we are committed to expanding access ...
The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...
Poolbeg Pharma has announced that the European Patent Office has granted its European Immunomodulator II patent application ...
GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...
Cellbyte, a Munich-based AI-native platform helping pharmaceutical companies accelerate drug launches, has raised $2.75 ...
Protara Therapeutics has announced encouraging interim results from its ongoing phase 2 STARBORN-1 trial evaluating TARA-002 ...
Biogen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has ...
New ONE BioHub facility expands clinical trial access and strengthens Scotland’s brain health innovation Scottish Brain Sciences (SBS) has opened a new clinical research centre at ONE BioHub in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback